NARCOLEPSY
Clinical trials for NARCOLEPSY explained in plain language.
Never miss a new study
Get alerted when new NARCOLEPSY trials appear
Sign up with your email to follow new studies for NARCOLEPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for long-term control of sudden muscle weakness and sleepiness in narcolepsy
Disease control CompletedThis study tested whether the drug AXS-12 could safely control two main narcolepsy symptoms—cataplexy (sudden muscle weakness) and excessive daytime sleepiness—over a longer period. It involved 68 people with narcolepsy who had already taken part in a previous trial. For 24 weeks…
Matched conditions: NARCOLEPSY
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New narcolepsy Drug's Real-World impact tracked in patient study
Disease control CompletedThis study observed how patients with narcolepsy responded to LUMRYZ treatment in everyday clinical practice. Over 70 adults who were prescribed LUMRYZ completed questionnaires about their sleepiness, symptoms, and quality of life for four months. The goal was to understand how t…
Matched conditions: NARCOLEPSY
Sponsor: Avadel • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New One-Dose-Nightly pill tested for narcolepsy safety
Disease control CompletedThis study tested the long-term safety and tolerability of a new, once-nightly version of a narcolepsy medication called FT218. It involved 184 people with narcolepsy, including those already taking a similar twice-nightly drug and those new to this type of treatment. The main go…
Matched conditions: NARCOLEPSY
Phase: PHASE3 • Sponsor: Avadel • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New narcolepsy pill tested for side effects
Symptom relief CompletedThis study tested how well adults with narcolepsy tolerated a new, delayed-release version of a medication called pitolisant. The goal was to see if starting at the full treatment dose caused too many side effects or led people to stop taking it. Researchers monitored 46 particip…
Matched conditions: NARCOLEPSY
Phase: PHASE1 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Symptom relief
Last updated Mar 19, 2026 14:56 UTC
-
Scientists probe why sleepy kids gain weight
Knowledge-focused CompletedThis study aimed to understand why children with narcolepsy often gain weight and become obese. Researchers measured the metabolism, physical activity, and food intake of 24 children with narcolepsy over several days. The goal was to find the biological reason for the weight gain…
Matched conditions: NARCOLEPSY
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC